Home
GRFS
GRFS News

Latest Grifols S.A. (GRFS) News on December 18, 2024

Grifols’ Worst-Ever Year Can’t Derail Analyst Calls to Buy

Bloomberg

5 days ago

Grifols’ Worst-Ever Year Can’t Derail Analyst Calls to Buy

Grifols Keeps Door Open to Brookfield With Special Bond Term

Bloomberg

5 days ago

Grifols Keeps Door Open to Brookfield With Special Bond Term

MT Newswires

6 days ago

Sector Update: Health Care Stocks Retreat Late Afternoon

MT Newswires

6 days ago

Sector Update: Health Care

MT Newswires

6 days ago

Market Chatter: Grifols' Debt Placement Includes Early Redemption Option for Brookfield Asset Management

Flat Footed Asks Grifols to Reform Board to Protect Shareholders

Bloomberg

8 days ago

Flat Footed Asks Grifols to Reform Board to Protect Shareholders

Morningstar Research

12 days ago

Analyst Report: Grifols, S.A.

SEC Drops Probe Into Gotham Over Report on Grifols’ Accounts

Bloomberg

13 days ago

SEC Drops Probe Into Gotham Over Report on Grifols’ Accounts

Exploring High Growth Tech Stocks This December 2024

Simply Wall St.

14 days ago

Exploring High Growth Tech Stocks This December 2024

Grifols Shareholder Mason Capital Calls for Board Overhaul

Bloomberg

15 days ago

Grifols Shareholder Mason Capital Calls for Board Overhaul

MT Newswires

16 days ago

Sector Update: Health Care Stocks Slipping Late Afternoon

MT Newswires

16 days ago

Market Chatter: Grifols Shareholder Mason Capital Seeks Board Revamp

MT Newswires

19 days ago

Market Chatter: Grifols in Talks With Banks to Extend Credit Facility, Refinance Bonds

Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?

Benzinga

19 days ago

Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?

Grifols Stock Declines After Brookfield Drops Buyout Offer

Zacks

20 days ago

Grifols Stock Declines After Brookfield Drops Buyout Offer

Billionaire Grifols Family Woes in Focus as Brookfield Exits

Bloomberg

20 days ago

Billionaire Grifols Family Woes in Focus as Brookfield Exits

Grifols In Talks to Refinance Debt, Credit Line, CEO Says

Bloomberg

20 days ago

Grifols In Talks to Refinance Debt, Credit Line, CEO Says

MT Newswires

21 days ago

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires

21 days ago

Sector Update: Health Care

MT Newswires

21 days ago

Top Midday Decliners

MT Newswires

21 days ago

Sector Update: Health Care Stocks Advance Wednesday Afternoon

MT Newswires

21 days ago

Update: Market Chatter: Grifols' Family Won't Welcome Other Takeover Bids as Brookfield Walks Away

MT Newswires

21 days ago

Sector Update: Health Care Stocks Rise Pre-Bell Wednesday

Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols

Bloomberg

21 days ago

Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols

MT Newswires

21 days ago

Market Chatter: Brookfield Set to Drop Grifols Bid as Family Shuns Others

Brookfield Set to Drop Grifols Bid as Family Shuns Others

Bloomberg

21 days ago

Brookfield Set to Drop Grifols Bid as Family Shuns Others

MT Newswires

21 days ago

Market Chatter: Grifols' Family Won't Welcome Other Takeover Bids as Brookfield Walks Away

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

Zacks

a month ago

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment

Clinical Trials Arena

a month ago

GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment

Grifols Signals It Would Reject $6.8 Billion Brookfield Bid

Bloomberg

a month ago

Grifols Signals It Would Reject $6.8 Billion Brookfield Bid

Morningstar Research

a month ago

Analyst Report: Grifols, S.A.

MT Newswires

a month ago

Brookfield Asset Management Mulls $6.8 Billion Bid for Grifols

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

GlobeNewswire

a month ago

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

Brookfield Weighs €6.45 Billion Bid for Grifols; Shares Drop

Bloomberg

a month ago

Brookfield Weighs €6.45 Billion Bid for Grifols; Shares Drop

MT Newswires

a month ago

Market Chatter: Canada's Brookfield Reportedly Plans to Offer About 7-billion Euros For Spanish drugmaker Grifols

Banks to Pitch Roughly €11 Billion Buyout Debt for Grifols

Bloomberg

a month ago

Banks to Pitch Roughly €11 Billion Buyout Debt for Grifols

Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ...

GuruFocus.com

a month ago

Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ...

Morningstar Research

a month ago

Analyst Report: Grifols, S.A.

MT Newswires

a month ago

Market Chatter: Brookfield Asset Management Seeks Details of Grifols Related-Party Deals

Brookfield Seeks More Information on Grifols Related-Party Deals

Bloomberg

a month ago

Brookfield Seeks More Information on Grifols Related-Party Deals

High Growth Tech Stocks to Watch in November 2024

Simply Wall St.

2 months ago

High Growth Tech Stocks to Watch in November 2024

Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value

Simply Wall St.

2 months ago

Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value

Grifols receives FDA approval to treat surgical bleeding with FS solution

TipRanks

2 months ago

Grifols receives FDA approval to treat surgical bleeding with FS solution

MT Newswires

2 months ago

Grifols's Fibrin Sealant Approved by FDA for Children; Shares Rise

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

GlobeNewswire

2 months ago

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

MT Newswires

2 months ago

Grifols Teams Up With BARDA to Test Treatment for Eye Injuries Caused by Mustard Gas

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

GlobeNewswire

2 months ago

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

MT Newswires

3 months ago

Grifols Unit Wins US Government Contract to Develop Botulinum Neurotoxin Therapy

High Growth Tech Stocks To Watch In October 2024

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In October 2024

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

GlobeNewswire

3 months ago

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

MT Newswires

3 months ago

Market Chatter: Brookfield Seeks More Time to Complete Due Diligence for Possible Grifols Takeover Bid

MT Newswires

3 months ago

Sector Update: Health Care Stocks Fall Late Afternoon

MT Newswires

3 months ago

Grifols Among Companies to Face Spanish Regulator's Disciplinary Proceedings

Grifols Investor Group With 7.7% Holding Seeks Seat on Board

Bloomberg

3 months ago

Grifols Investor Group With 7.7% Holding Seeks Seat on Board

MT Newswires

3 months ago

Sector Update: Health Care Stocks Rise Friday Afternoon

Orange, Grifols Egypt Team Up to Advance Egypt's Healthcare System

Zacks

3 months ago

Orange, Grifols Egypt Team Up to Advance Egypt's Healthcare System

MT Newswires

3 months ago

Market Chatter: Grifols Seeking Consultants to Fend off Shareholder Challenge

MT Newswires

3 months ago

Grifols Egypt Partners With Orange for Data Center, Communications Infrastructure

Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’

Bloomberg

3 months ago

Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’

Grifols Postpones Capital Markets Day Amid Potential Takeover

Bloomberg

3 months ago

Grifols Postpones Capital Markets Day Amid Potential Takeover

MT Newswires

4 months ago

Update: Market Chatter: Brookfield in Talks With Sovereign Funds to Join Grifols Acquisition Bid

MT Newswires

4 months ago

Market Chatter: Brookfield in Talks With Sovereign Funds to Join Grifols Acquisition Bid

Brookfield Courts Sovereign Funds to Join Grifols Takeover Bid

Bloomberg

4 months ago

Brookfield Courts Sovereign Funds to Join Grifols Takeover Bid

This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future

The Wall Street Journal

4 months ago

This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday

Zacks

4 months ago

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday

MT Newswires

4 months ago

Sector Update: Health Care

Brookfield in talks with banks for funding Grifols' takeover bid, sources say

Reuters

4 months ago

Brookfield in talks with banks for funding Grifols' takeover bid, sources say

MT Newswires

4 months ago

European Equities Close Mostly Higher in Wednesday Trading; CMA Closes Probes Into Google, Apple

Brookfield Seeks Nearly €10 Billion to Back Grifols Takeover

Bloomberg

4 months ago

Brookfield Seeks Nearly €10 Billion to Back Grifols Takeover

Investing.com

4 months ago

Grifols shares up on potential takeover by Brookfield

Azvalor Iberia FI's Strategic Moves in Q2 2024: Spotlight on Linea Directa Aseguradora SA

GuruFocus.com

4 months ago

Azvalor Iberia FI's Strategic Moves in Q2 2024: Spotlight on Linea Directa Aseguradora SA

Associated Press Finance

5 months ago

Grifols: Q2 Earnings Snapshot

GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339

GlobeNewswire

5 months ago

GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339

Morningstar Research

5 months ago

Analyst Report: Grifols, S.A.

MT Newswires

5 months ago

Sector Update: Health Care Stocks Softer Tuesday Afternoon

MT Newswires

5 months ago

Market Chatter: Grifols Revises Financial Records Lower by $494 Million to Adjust Value Shanghai RAAS Stake

Grifols’ New Auditor Discovers Non-Cash Accounting Discrepancy Linked to China Stake

Bloomberg

5 months ago

Grifols’ New Auditor Discovers Non-Cash Accounting Discrepancy Linked to China Stake

MT Newswires

5 months ago

Grifols Gets US FDA Approval for Expanded Label of Xembify

Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients

GlobeNewswire

5 months ago

Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients

Three Stocks Estimated To Be Trading With Intrinsic Discounts Between 35.9% And 49.7%

Simply Wall St.

5 months ago

Three Stocks Estimated To Be Trading With Intrinsic Discounts Between 35.9% And 49.7%

Grifols Family Shareholders, Brookfield in Talks To Take Firm Private

Investopedia

5 months ago

Grifols Family Shareholders, Brookfield in Talks To Take Firm Private

MT Newswires

5 months ago

Grifols Shares Surge on Take-Private Talks

MT Newswires

5 months ago

European Equities Close Mixed in Monday Trading

Morningstar Research

5 months ago

Analyst Report: Grifols, S.A.

Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why

Benzinga

5 months ago

Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why

MT Newswires

5 months ago

Market Chatter: Grifols Says Founding Family, Brookfield Weigh Takeover Bid

Grifols Says Founding Family, Brookfield Weigh Takeover Bid

Bloomberg

5 months ago

Grifols Says Founding Family, Brookfield Weigh Takeover Bid

MT Newswires

5 months ago

Sector Update: Health Care

MT Newswires

5 months ago

Grifols Appoints New Chief Financial Officer

Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

GlobeNewswire

6 months ago

Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

Grifols Leads Three Stocks That May Be Priced Below Their Estimated True Value

Simply Wall St.

6 months ago

Grifols Leads Three Stocks That May Be Priced Below Their Estimated True Value

Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group

GlobeNewswire

6 months ago

Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group

Biotest wins FDA approval for plasma protein therapy

Pharmaceutical Technology

6 months ago

Biotest wins FDA approval for plasma protein therapy

Grifols prepares for late-stage plans with plasma-derived medicines in 2024

Pharmaceutical Technology

6 months ago

Grifols prepares for late-stage plans with plasma-derived medicines in 2024

MT Newswires

6 months ago

Grifols' Biotest Gets FDA Approval for Yimmugo

Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies

GlobeNewswire

6 months ago

Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies

Morningstar Research

6 months ago

Analyst Report: Grifols, S.A.

GigaGen doses first subject in Phase I advanced solid tumour trial

Clinical Trials Arena

7 months ago

GigaGen doses first subject in Phase I advanced solid tumour trial

Morningstar Research

7 months ago

Analyst Report: Grifols, S.A.

Short Seller Gains on Grifols Bet That Tripped Elliott Spinout

Bloomberg

7 months ago

Short Seller Gains on Grifols Bet That Tripped Elliott Spinout

Share on Social Networks: